Citations

Mayo Clinic

Showing 10 of 108522 citations.

RNA interference screening identifies lenalidomide sensitizers in multiple myeloma, including RSK2
Zhu, Yuan Xiao , Yin, Hongwei , Bruins, Laura A., Shi, Chang-Xin, Jedlowski, Patrick , Aziz, Meraj , Sereduk, Chris , Kortuem, K. Martin, Schmidt, Jessica, Champion, Mia D., Braggio, Esteban , Stewart, A. Keith, Kortuem, Klaus Martin, Schmidt, Jessica E, Champion, Mia, Braggio, Esteban

Blood | November 14, 2014 | Volume: 125 | Issue: 3 | Pages: 483-491

10.1182/blood-2014-05-577130 | PMID 25395420 Get It

Key Points High-throughput RNAi screening identified lenalidomide sensitizer genes, including RSK2, RAB, peroxisome, and potassium channel family members. Knockdown or inhibition of RSK2 synergized with lenalidomide to induce myeloma cytotoxicity and downregulation of interferon regulatory factor 4 and MYC.
Atypical endometrial cells and atypical glandular cells favor endometrial origin in Papanicolaou cervicovaginal tests: Correlation with histologic follow-up and abnormal clinical presentations
Booth, Christine N. , Shorie, Julie, Brainard, Jennifer , Zarka, Matthew A., Chen, Longwen

CytoJournal | November 14, 2014 | Volume: 11 | Issue: No issue available | Pages: 29

10.4103/1742-6413.144686 | PMID 25506385 Get It

The 2001 Bethesda system recommends further classifying atypical glandular cells (AGCs) as either endocervical or endometrial origin. Numerous studies have investigated the clinical significance of AGC. In this study, we investigated the incidence of clinically significant lesions among women with liquid-based Papanicolaou cervicovaginal (Pap) interpretations of atypical endometrial cells (AEMs) or AGC favor endometrial origin (AGC-EM). More importantly, we correlated patients of AEM or AGC-EM with their clinical presentations to determine if AEM/AGC-EM combined with abnormal vaginal bleeding is associated with a higher incidence of significant endometrial pathology. All liquid-based Pap tests with an interpretation of AEM and AGC-EM from July, 2004 through June, 2009 were retrieved from the database. Women with an interpretation of atypical endocervical cells, AGC, favor endocervical origin or AGC, favor neoplastic were not included in the study. The most severe subsequent histologic diagnoses were recorded for each patient. During this 5-year period, we accessioned 332,470 Pap tests of which 169 (0.05%) were interpreted as either AEM or AGC-EM. Of the 169 patients, 133 had histologic follow-up within the health care system. The patients ranged in age from 21 to 71 years old (mean 49.7). On follow-up histology, 27 (20.3%) had neoplastic/preneoplastic uterine lesions. Among them, 20 patients were diagnosed with adenocarcinoma (18 endometrial, 1 endocervical, and 1 metastatic colorectal), 3 with atypical endometrial hyperplasia, and 4 with endometrial hyperplasia without atypia. All patients with significant endometrial pathology, except one, were over 40 years old, and 22 of 25 patients reported abnormal vaginal bleeding at the time of endometrial biopsy or curettage. This study represents a large series of women with liquid-based Pap test interpretations of AEM and AGC-EM with clinical follow-up. Significant preneoplastic or neoplastic endometrial lesions were identified in 20.3% of patients. Patients with Pap test interpretations of AEM or AGC-EM and the clinical presentation of abnormal vaginal bleeding should be followed closely.
Dinaciclib, a novel CDK inhibitor, demonstrates encouraging single-agent activity in patients with relapsed multiple myeloma
Kumar, Shaji , LaPlant, Betsy, Zonder, Jeffrey A. , Fruth, Briant, Erlichman, Charles , Stewart, A. Keith, Kumar, Shaji K , Chng, Wee Joo , Callander, Natalie S. , Fonseca, Rafaël , Roy, Vivek

Blood | November 14, 2014 | Volume: 125 | Issue: 3 | Pages: 443-448

10.1182/blood-2014-05-573741 | PMID 25395429 Get It

Key Points Dinaciclib is a novel cdk inhibitor that demonstrates single agent activity in myeloma. Dinaciclib has a safety profile that is easily manageable.
From Vitamin K Antagonists to Liver International Normalized Ratio: A Historical Journey and Critical Perspective
Gatt, Alexander, Chen, Dong , Pruthi, Rajiv K. , Kamath, Patrick S. , Leise, Michael D. , Ashrani, Aneel A. , Nichols, William G, He, Rong , Nichols, William L., Nichols, W. Garrett , Chen, Dong

Seminars in Thrombosis and Hemostasis | November 13, 2014 | Volume: 40 | Issue: 08 | Pages: 845-851

10.1055/s-0034-1395160 | PMID 25393635 Get It

Unique molecular signatures of Alzheimer's disease amyloid β peptide mutations and deletion during aggregate/oligomer/fibril formation
Poduslo, Joseph F., Howell, Kyle G.

Journal of Neuroscience Research | November 13, 2014 | Volume: 93 | Issue: 3 | Pages: 410-423

10.1002/jnr.23507 | PMID 25377128 Get It

The formation of amyloid β (Aβ) peptide aggregates, oligomers, and fibrils is a dynamic process; however, the kinetics of their formation is not well understood. This study compares the time course of aggregate/fibril formation by transmission electron microscopy (TEM) analyses with that of oligomer/fibril formation by Western blot analysis under native and denaturing conditions. Efforts to deaggregate/defibrillate these peptides by using hexafluoroisopropanol, ammonium hydroxide, or dimethylsulfoxide did not change the nondenaturing polyacrylamide gel electrophoresis (PAGE) footprints or drive the peptides to a monomeric species. Regardless of the pretreatment protocol, TEM analyses reveal that all Aβ peptides (Aβ40, Aβ42, Aβ39E22Δ [Osaka], Aβ40E22G [Arctic], Aβ40E22Q [Dutch], and Aβ40A2T [Icelandic]) immediately formed nonfibrillar, amorphous aggregates when first placed into solution with the Osaka mutation, quickly forming early‐stage fibrils. The extent of fibril formation for other Aβ peptides is time dependent, with the Arctic mutation forming fibrils at 1 hr, the Dutch and Icelandic at 4 hr, Aβ42 at 8 hr, and Aβ40 at 24 hr. In contrast, nondenaturing PAGE revealed unique footprints for the different Aβ species. The rapidity of aggregate formation and the rapid transition to fibrils, particularly for the Osaka deletion, suggest an important role for aggregates/fibrils of Aβ in the development of neuronal degeneration. © 2014 Wiley Periodicals, Inc.
Variations in lipid screening frequency in family medicine patients with cardiovascular risk factors
Doğaner, Yusuf Çetin , Rohrer, James E. , Angstman, Kurt B. , Merry, Stephen , Erickson, Jacob L. , Doganer, Yusuf C, Merry, Stephen P

Journal of Evaluation in Clinical Practice | November 13, 2014 | Volume: 21 | Issue: 2 | Pages: 215-220

10.1111/jep.12290 | PMID 25394299 Get It

AbstractRationale, aims and objectivesThis study was undertaken to assess the frequency of lipid screening in comparison with the United States Preventive Services Task Force guideline in a sample of family medicine patients. In addition, we sought to determine the association between testing frequency and achievement of lipid targets.MethodsA random sample was extracted from 271 patients from among all patients cared for in our Department of Family Medicine for whom lipid screening was ordered from March to September 2012 and who had ≥2 well‐defined cardiovascular risk factors. Lipid testing frequency was classified in three ways: semi‐annual or less often (0–12 tests over 6 years), annual or less often (0–6 tests), or biennial (0–3 tests).ResultsMultiple logistic regression analysis revealed that the predictors of lipid screening more often than semi‐annually were age ≥60 years [odds ratio (OR) = 3.7] and diabetes mellitus (DM) (OR = 30.6). Predictors of screening more often than annually were DM (OR = 4.3), hypertension (OR = 2.1), family history of premature coronary artery disease (OR = 5.6) and statin treatment (OR = 3.5). Lipid goal attainment was not associated with testing frequency except with regard to low‐density lipoprotein levels (P = 0.043, P < 0.001, P = 0.005, by semi‐annual, annual and biennial, respectively) and total cholesterol levels (P = 0.015, P = 0.025 by semi‐annual and annual, respectively).ConclusionsQuestionable high frequency of lipid testing was detected even when the more conservative approach of annual monitoring was assumed. Frequency of testing was not associated with goal attainment for most parameters. Physicians should request the lipid testing based on overall risk assessment and person variability in accordance with published guidelines.
Acute cutaneous graft‐vs.‐host disease compared to drug hypersensitivity reaction with vacuolar interface changes: a blinded study of microscopic and immunohistochemical features
Lehman, Julia S. , Gibson, Lawrence E. , Chavan, Rahul N. , Hashmi, Shahrukh K. , Lohse, Christine M. , Flotte, Thomas J. , el‐Azhary, Rokea A. , Lehman, Julia S

Journal of Cutaneous Pathology | November 13, 2014 | Volume: 42 | Issue: 1 | Pages: 39-45

10.1111/cup.12427 | PMID 25393781 Get It

BackgroundComplications from graft‐vs.‐host disease (GVHD), a major contributor to morbidity and mortality following hematopoietic cell transplantation, may be mitigated by early diagnosis and intervention. However, differentiation between acute cutaneous GVHD and other common skin eruptions that develop in the post‐transplantation period, such as drug hypersensitivity reaction, can be challenging clinically and microscopically. Because recent evidence indicates that CD123, a marker of plasmacytoid dendritic cells, can help to distinguish gastrointestinal GVHD from the clinicopathologic mimic cytomegalovirus colitis, we aimed to determine whether CD123 could aid in the diagnosis of acute cutaneous GVHD.MethodsWe studied 12 skin specimens of patients with grades I–II cutaneous GVHD and 12 from patients who had drug hypersensitivity reaction with vacuolar interface changes on biopsy.ResultsNo differences were seen between the two groups with regards to density or distribution of CD123 expression. Specimens representing GVHD showed significantly less spongiosis (P < 0.001) and fewer dermal eosinophils (P = 0.03) compared to those representing drug hypersensitivity reaction.ConclusionsWe conclude that CD123 does not appear to be a useful ancillary test in the diagnosis of acute cutaneous GVHD. Careful correlation between clinical findings and features with microscopy remains the cornerstone of accurate diagnosis of acute cutaneous GVHD.
Perilipin 5 Regulates Islet Lipid Metabolism and Insulin Secretion in a cAMP-Dependent Manner: Implication of Its Role in the Postprandial Insulin Secretion
Trevino, Michelle B., Machida, Yui, Hallinger, Daniel R. , Garcia, Eden, Christensen, Aaron, Dutta, Sucharita , Peake, David A., Ikeda, Yasuhiro , Imai, Yumi

Diabetes | November 13, 2014 | Volume: 64 | Issue: 4 | Pages: 1299-1310

10.2337/db14-0559 | PMID 25392244 Get It

Elevation of circulating fatty acids (FA) during fasting supports postprandial (PP) insulin secretion that is critical for glucose homeostasis and is impaired in diabetes. We tested our hypothesis that lipid droplet (LD) protein perilipin 5 (PLIN5) in β-cells aids PP insulin secretion by regulating intracellular lipid metabolism. We demonstrated that PLIN5 serves as an LD protein in human islets. In vivo, Plin5 and triglycerides were increased by fasting in mouse islets. MIN6 cells expressing PLIN5 (adenovirus [Ad]-PLIN5) and those expressing perilipin 2 (PLIN2) (Ad-PLIN2) had higher [3H]FA incorporation into triglycerides than Ad-GFP control, which support their roles as LD proteins. However, Ad-PLIN5 cells had higher lipolysis than Ad-PLIN2 cells, which increased further by 8-Br-cAMP, indicating that PLIN5 facilitates FA mobilization upon cAMP stimulation as seen postprandially. Ad-PLIN5 in islets enhanced the augmentation of glucose-stimulated insulin secretion by FA and 8-Br-cAMP in G-protein–coupled receptor 40 (GPR40)- and cAMP-activated protein kinase–dependent manners, respectively. When PLIN5 was increased in mouse β-cells in vivo, glucose tolerance after an acute exenatide challenge was improved. Therefore, the elevation of islet PLIN5 during fasting allows partitioning of FA into LD that is released upon refeeding to support PP insulin secretion in cAMP- and GPR40-dependent manners.
Current research on the treatment of primary sclerosing cholangitis
Ali, Ahmad H. , Carey, Elizabeth J. , Lindor, Keith D.

Intractable & Rare Diseases Research | November 13, 2014 | Volume: 4 | Issue: 1 | Pages: 1-6

10.5582/irdr.2014.01018 | PMID 25674381 Get It

Interventional pulmonology: The tipping point
Maldonado, Fabien , Edell, Eric S. , Barron, Patrick J., Yung, Rex

Respirology | November 13, 2014 | Volume: 20 | Issue: 1 | Pages: 11-12

10.1111/resp.12431 | PMID 25393062 Get It